Evidence map›Paper›PMID 27467073›Full record

ReviewAnnals of the New York Academy of Sciences2016

Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents.

Isaac N Pessah, Michael A Rogawski, Daniel J Tancredi, Heike Wulff, Dorota Zolkowska, Donald A Bruun, Bruce D Hammock, Pamela J Lein

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Isaac N PessahDepartment of Molecular Biosciences, School of Veterinary Medicine.
Michael A RogawskiDepartment of Neurology, School of Medicine.
Daniel J TancrediDepartment of Pediatrics, School of Medicine.
Heike WulffDepartment of Pharmacology, School of Medicine.
Dorota ZolkowskaDepartment of Neurology, School of Medicine.
Donald A BruunDepartment of Molecular Biosciences, School of Veterinary Medicine.
Bruce D HammockDepartment of Entomology, College of Agricultural and Environmental Sciences, University of California, Davis, Davis, California.
Pamela J LeinDepartment of Molecular Biosciences, School of Veterinary Medicine. pjlein@ucdavis.edu.
Zero to Three · USJohns Hopkins Medicine · USUniversity of California, Davis · US

Funding

Training and Education CoreU54NS079202 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEIN, PAMELA J · 2012 to 2021
$35.7M
NINDS NIH HHS U54 NS079202
6 · The paper itself

Abstract

Exposures to seizure-inducing chemical threat agents are a major public health concern. Of particular need is improved treatment to terminate convulsions and to prevent the long-term neurological sequelae in survivors. We are studying the organophosphorus cholinesterase inhibitor diisopropyl fluorophosphate (DFP) and the GABA receptor inhibitor tetramethylenedisulfotetramine (TETS), which arguably encompass the mechanistic spectrum of seizure-inducing chemical threats, with the goal of identifying therapeutic approaches with broad-spectrum efficacy. Research efforts have focused on developing translational models and translational diagnostic approaches, including (1) in vivo models of DFP- and TETS-induced seizures for studying neuropathological mechanisms and identifying treatment approaches; (2) in vivo imaging modalities for noninvasive longitudinal monitoring of neurological damage and response to therapeutic candidates; and (3) higher-throughput in vitro platforms for rapid screening of compounds to identify potential antiseizure and neuroprotective agents, as well as mechanistically relevant novel drug targets. This review summarizes our progress toward realizing these goals and discusses best practices and mechanistic insights derived from our modeling efforts.

Indexed as

AnimalsAnticonvulsantsBrainBridged-Ring CompoundsCholinesterase InhibitorsDisease Models, AnimalHumansIsoflurophateNeuroprotective AgentsOrganophosphate PoisoningSeizuresTreatment OutcomeAnticonvulsantsBridged-Ring CompoundsCholinesterase InhibitorsIsoflurophateNeuroprotective Agentstetramethylenedisulfotetraminediisopropyl fluorophosphateorganophosphateseizuresstatus epilepticustetramethylenedisulfotetramine

Identifiers

PMID27467073
PMCPMC5063690
OpenAlexW2500216261

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.